Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 144
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Ann Chir Plast Esthet ; 67(4): 261-263, 2022 Sep.
Artículo en Francés | MEDLINE | ID: mdl-35927108

RESUMEN

The pilonidal cyst is an inflammatory disease occurring when a hair follicle penetrates inside a surgical wound. Uncommon in the scalp region, the pilonidal sinus is typically encountered in the sacrococcygeal regions. A single minor trauma of the scalp can be an inductor factor. The surgical treatment includes one-piece excision of the cyst followed by direct closure. We report a case of a 4-year-old child presenting a pilonidal sinus of the scalp following a single minor trauma.


Asunto(s)
Quistes , Seno Pilonidal , Enfermedades de la Piel , Preescolar , Humanos , Recurrencia , Región Sacrococcígea , Cuero Cabelludo
2.
Arch Gynecol Obstet ; 303(6): 1425-1432, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33211176

RESUMEN

PURPOSE: Early pregnancy loss leads to a devastating situation for many couples. Genetic disorders found in the pregnancy tissue are a frequent cause of miscarriages. It is unclear whether maternal age or previous miscarriages are associated with a higher chromosomal anomaly rate. This study aimed to determine the cytogenetical distribution of chromosomal disorders in couples after one or more previous miscarriages as well as the influence of maternal age. METHODS: 406 fetal tissue samples obtained after spontaneous abortion between 2010 and 2014 were successfully karyotyped. This included 132 couples with at least two losses and 274 couples with sporadic miscarriage. Normal and abnormal karyotype rate was determined for age, parity, gravidity, gestational week and number of previous miscarriages by logistic regression analysis. RESULTS: 145 (35.71%) fetal tissue samples had a normal karyotype, and 261 (64.8%) did not. After adjusting for age, older patients have a statistically significantly higher probability of genetic disorders in the pregnancy tissue (p < 0.001, OR 1.064, 95% CI 1.03-1.11). With each additional year, the probability of finding chromosomal abnormalities in a miscarriage increased by 6.4%. Patients younger than 35 years have a lower probability of having chromosomal disorders in the aborted material after two or more miscarriages than after sporadic miscarriages (50.7 vs. 58.9%) (p = 0.014, OR 0.67, 95% CI 0.48-0.914). Nevertheless, the risk of embryonic chromosomal disorders in patients aged 35 and above increased from 75.5% in sporadic miscarriages to 82.4% after more than one pregnancy losses (p = 0.59, OR 1.14, 95% CI - 0.72 to 1.92). CONCLUSION: Chromosomal disorders found after one or more previous miscarriages are related to patients' age. Couples suffering two or more miscarriages should be further researched, especially in younger patients.


Asunto(s)
Aborto Habitual/epidemiología , Aborto Espontáneo/genética , Trastornos de los Cromosomas , Aborto Espontáneo/etiología , Adolescente , Adulto , Aberraciones Cromosómicas , Trastornos de los Cromosomas/genética , Trastornos de los Cromosomas/patología , Femenino , Humanos , Cariotipificación , Edad Materna , Persona de Mediana Edad , Embarazo , Estudios Retrospectivos
3.
Br J Surg ; 107(3): 268-277, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31916594

RESUMEN

BACKGROUND: The aim was to analyse the impact of cirrhosis on short-term outcomes after laparoscopic liver resection (LLR) in a multicentre national cohort study. METHODS: This retrospective study included all patients undergoing LLR in 27 centres between 2000 and 2017. Cirrhosis was defined as F4 fibrosis on pathological examination. Short-term outcomes of patients with and without liver cirrhosis were compared after propensity score matching by centre volume, demographic and tumour characteristics, and extent of resection. RESULTS: Among 3150 patients included, LLR was performed in 774 patients with (24·6 per cent) and 2376 (75·4 per cent) without cirrhosis. Severe complication and mortality rates in patients with cirrhosis were 10·6 and 2·6 per cent respectively. Posthepatectomy liver failure (PHLF) developed in 3·6 per cent of patients with cirrhosis and was the major cause of death (11 of 20 patients). After matching, patients with cirrhosis tended to have higher rates of severe complications (odds ratio (OR) 1·74, 95 per cent c.i. 0·92 to 3·41; P = 0·096) and PHLF (OR 7·13, 0·91 to 323·10; P = 0·068) than those without cirrhosis. They also had a higher risk of death (OR 5·13, 1·08 to 48·61; P = 0·039). Rates of cardiorespiratory complications (P = 0·338), bile leakage (P = 0·286) and reoperation (P = 0·352) were similar in the two groups. Patients with cirrhosis had a longer hospital stay than those without (11 versus 8 days; P = 0·018). Centre expertise was an independent protective factor against PHLF in patients with cirrhosis (OR 0·33, 0·14 to 0·76; P = 0·010). CONCLUSION: Underlying cirrhosis remains an independent risk factor for impaired outcomes in patients undergoing LLR, even in expert centres.


ANTECEDENTES: El objetivo de este estudio fue analizar el impacto de la cirrosis en los resultados a corto plazo después de la resección hepática laparoscópica (laparoscopic liver resection, LLR) en un estudio de cohortes multicéntrico nacional. MÉTODOS: Este estudio retrospectivo incluyó todos los pacientes sometidos a LLR en 27 centros entre 2000 y 2017. La cirrosis se definió como fibrosis F4 en el examen histopatológico. Los resultados a corto plazo de los pacientes con hígado cirrótico (cirrhotic liver CL) (pacientes CL) y los pacientes con hígado no cirrótico (non-cirrhotic liver, NCL) (pacientes NCL) se compararon después de realizar un emparejamiento por puntaje de propension del volumen del centro, las características demográficas y del tumor, y la extensión de la resección. RESULTADOS: Del total de 3.150 pacientes incluidos, se realizó LLR en 774 (24,6%) pacientes CL y en 2.376 (75,4%) pacientes NCL. Las tasas de complicaciones graves y mortalidad en el grupo de pacientes CL fueron del 10,6% y 2,6%, respectivamente. La insuficiencia hepática posterior a la hepatectomía (post-hepatectomy liver failure, PHLF) fue la principal causa de mortalidad (55% de los casos) y se produjo en el 3,6% de los casos en pacientes CL. Después del emparejamiento, los pacientes CL tendieron a tener tasas más altas de complicaciones graves (razón de oportunidades, odds ratio, OR 1,74; i.c. del 95% 0,92-0,41; P = 0,096) y de PHLF (OR 7,13; i.c. del 95% 0,91-323,10; P = 0,068) en comparación con los pacientes NCL. Los pacientes CL estuvieron expuestos a un mayor riesgo de mortalidad (OR 5,13; i.c. del 95% 1,08-48,6; P = 0,039) en comparación con los pacientes NCL. Los pacientes CL presentaron tasas similares de complicaciones cardiorrespiratorias graves (P = 0,338), de fuga biliar (P = 0,286) y de reintervenciones (P = 0,352) que los pacientes NCL. Los pacientes CL tuvieron una estancia hospitalaria más larga (11 versus 8 días; P = 0,018) que los pacientes NCL. La experiencia del centro fue un factor protector independiente de PHLF (OR 0,33; i.c. del 95% 0,14-0,76; P = 0,010) pacientes CL. CONCLUSIÓN: La presencia de cirrosis subyacente sigue siendo un factor de riesgo independiente de peores resultados en pacientes sometidos a resección hepática laparoscópica, incluso en centros con experiencia.


Asunto(s)
Carcinoma Hepatocelular/cirugía , Hepatectomía/efectos adversos , Laparoscopía/efectos adversos , Cirrosis Hepática/diagnóstico , Neoplasias Hepáticas/cirugía , Complicaciones Posoperatorias/diagnóstico , Puntaje de Propensión , Anciano , Supervivencia sin Enfermedad , Femenino , Humanos , Cirrosis Hepática/etiología , Masculino , Persona de Mediana Edad , Vigilancia de la Población , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Factores de Riesgo
4.
Genet Mol Res ; 14(1): 1044-55, 2015 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-25730044

RESUMEN

Chronic myeloid leukemia (CML) is characterized by BCR-ABL translocation and an increased number and migration of immature myeloid cells into the peripheral blood. The detection limit of the BCR-ABL transcript, particularly after treatment, is controversial. In the present study, we used quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR) to monitor BCR-ABL expression in Moroccan CML patients undergoing imatinib treatment, and compared the results with those of conventional PCR and fluorescence in situ hybridization (FISH). The aim of this study was to establish a new molecular tool for in vitro diagnosis of CML. In a retrospective comparative analysis, 20 CML Moroccan patients who had received imatinib treatment (N = 20) were analyzed by real-time PCR, conventional RT-PCR, and FISH. Half of the samples analyzed (N = 10) were positive for BCR-ABL gene expression, while the other half (N = 10) were negative according to conventional PCR. Interestingly, 5 of the 10 samples shown to be negative by conventional PCR showed positive expression of the BCR-ABL gene according to RT-qPCR. The RT-qPCR results were confirmed by FISH, which revealed a high concordance (100%) rate. We found that real-time RT-qPCR is more reliable and should be used in Moroccan biomedical analysis laboratories to monitor CML progression, particularly for minimal residual disease, following imatinib treatment.


Asunto(s)
Proteínas de Fusión bcr-abl/genética , Leucemia Mielógena Crónica BCR-ABL Positiva/sangre , Leucemia Mielógena Crónica BCR-ABL Positiva/genética , Neoplasia Residual/sangre , Neoplasia Residual/genética , Adulto , Anciano , Femenino , Proteínas de Fusión bcr-abl/sangre , Humanos , Mesilato de Imatinib/efectos adversos , Hibridación Fluorescente in Situ , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Leucemia Mielógena Crónica BCR-ABL Positiva/patología , Masculino , Persona de Mediana Edad , Marruecos , Neoplasia Residual/inducido químicamente , Neoplasia Residual/patología , Patología Molecular , Reacción en Cadena en Tiempo Real de la Polimerasa , Estudios Retrospectivos
5.
Genet Mol Res ; 13(1): 791-8, 2014 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-24615043

RESUMEN

Germline mutations in the BRCA1 gene are known predictive markers for the development of hereditary breast cancer. Nevertheless, no comprehensive study has been performed targeting the presence and relevance of BRCA1 mutations in Moroccan breast cancer patients. We here present an analysis of BRCA1 gene regions (exon 2 and exon 11a/b) of 50 female Moroccan breast cancer patients with early disease onset (≤ 40 years) or familial disease backgrounds. Results showed that no mutation was present in either exon 2 or exon 11a of the BRCA1 gene in any of the 50 patients analysed. However, in exon 11b, a mutation generated by a nucleotide exchange was detected in 8% of patients, most of whom were young women (≤ 40). This mutation leads to substitution of the amino acid glutamine by an arginine at position 356 of the polypeptide sequence (Q356R). Although this mutation was previously characterised at a lower frequency in western populations, our study is the first to describe it in a young Moroccan population. Furthermore, another mutation was detected with a high frequency (4%) on exon 11b of the BRCA1 gene in exclusively young patients (≤ 40). This mutation was silent, encoding the same threonine residue at position 327 (T327T) as the wild type. The present study is the first to describe this mutation as well, particularly in a young Moroccan population. Analysis of a larger population is required in order to highlight the relevance of the Q356R and T327T mutations in young Moroccan breast cancer patients.


Asunto(s)
Proteína BRCA1/genética , Neoplasias de la Mama/genética , Predisposición Genética a la Enfermedad , Adulto , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Análisis Mutacional de ADN , Exones , Femenino , Humanos , Marruecos , Polimorfismo de Nucleótido Simple , Adulto Joven
6.
Clin Res Hepatol Gastroenterol ; 48(1): 102266, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38101698

RESUMEN

The presence of a pre-existing or recent extra-hepatic solid tumor was considered for a long time as an absolute contraindication to liver transplantation, by fear of futility with an unacceptable increase in non-liver-related mortality. However, cancer-related mortality in solid malignancies is heterogeneous, and experts suggest that case-by-case multidisciplinary decisions should be made. Here, we report the cases of 3 patients with favorable oncological and liver outcome in patients with renal cell carcinoma detected during pre-transplant evaluation that nonetheless underwent liver transplantation.


Asunto(s)
Carcinoma de Células Renales , Neoplasias Renales , Neoplasias Hepáticas , Trasplante de Hígado , Humanos , Carcinoma de Células Renales/cirugía , Neoplasias Hepáticas/cirugía , Neoplasias Renales/cirugía , Resultado del Tratamiento
7.
Ann Chir Plast Esthet ; 57(3): 308-11, 2012 Jun.
Artículo en Francés | MEDLINE | ID: mdl-20561737

RESUMEN

INTRODUCTION: Primary malignant schwannomas are rare neoplasms of nerve sheath origin, especially in the location of the head and neck where few cases are described in the literature. REPORT CASE: We report the case of a 65-year-old male diagnosed with malignant schwannoma in the left cheek. The patient underwent surgery with wide local excision, reconstruction were made later by skin graft. DISCUSSION: The treatment of choice is radical excision of the lesion with wide margins. In fact, to reduce local tumor recurrence, the use of adjuvant radiation or chemotherapy is still controversial.


Asunto(s)
Mejilla/inervación , Neoplasias de los Nervios Craneales/diagnóstico , Enfermedades del Nervio Facial/diagnóstico , Neurilemoma/diagnóstico , Anciano , Biomarcadores de Tumor/análisis , Biopsia , Mejilla/patología , Mejilla/cirugía , Neoplasias de los Nervios Craneales/patología , Neoplasias de los Nervios Craneales/cirugía , Enfermedades del Nervio Facial/patología , Enfermedades del Nervio Facial/cirugía , Humanos , Masculino , Índice Mitótico , Clasificación del Tumor , Neurilemoma/patología , Neurilemoma/cirugía , Reoperación , Proteínas S100/análisis , Trasplante de Piel
8.
Ann Burns Fire Disasters ; 35(1): 62-67, 2022 Mar 31.
Artículo en Francés | MEDLINE | ID: mdl-35582089

RESUMEN

When their treatment is not optimal, deep cervical burns often develop retractions, ranging between simple vertical retractions to major global ones. They generate functional, aesthetic and psychological sequelae. Surgical treatment, adapted to both the patient and the type of retraction, has several goals including restoring the neck-chin angle, restoring a correct aesthetic aspect, and allowing social rehabilitation. In our unit, we managed 47 patients (mean age 22) with neck contractures over 8 years, from 2012-2020. Scald is more frequent in children while flame burns prevail in adults. Most (58%) patients healed spontaneously. Moderate and severe contractures (Achauer's classification) accounted for 30.6 and 38.8% respectively. In most (94%) patients, the contracture leads to a distortion of the neck-chin angle and limits the extension of the neck. Surgery techniques were skin grafts (67.3%), local plasties (24.5%) and flaps (8.2%). During the follow-up, results were considered as good in 83%, acceptable in 8.5%, while 8.5% needed another surgery. Plasties (Z, IC, VY…) and local flaps (with or without skin expansions) are indicated in minor contractures. Authors still debate on the best technique (graft or flap) for severe and major ones. Post-operative rehabilitation is a cornerstone for good results.

9.
J Visc Surg ; 158(3): 279-280, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33303391

RESUMEN

Mesenteric and portal vein involvement is seen frequently in pancreatic neoplastic disease and requires venous resection to obtain clear surgical margins. If sufficient collateral circulation is present, venous resection can be performed without reconstruction and without substantial impact on venous drainage.


Asunto(s)
Venas Mesentéricas , Neoplasias Pancreáticas , Humanos , Venas Mesentéricas/diagnóstico por imagen , Venas Mesentéricas/cirugía , Pancreatectomía , Neoplasias Pancreáticas/cirugía , Pancreaticoduodenectomía , Vena Porta/diagnóstico por imagen , Vena Porta/cirugía
10.
J Visc Surg ; 158(5): 370-377, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-33461889

RESUMEN

INTRODUCTION: Pancreatic ascites (PA) is an unusual and little studied complication of chronic alcoholic pancreatitis. Management is complex and is based mainly on empirical data. The aim of this retrospective work was to analyse the management of PA at our centre. PATIENTS AND METHODS: A total of 24 patients with PA complicating chronic alcoholic pancreatitis were managed at the Lille University Hospital between 2004 and 2018. Treatment was initially medical and then, in case of failure, interventional (endoscopic, radiological and/or surgical). Data regarding epidemiology, therapeutic and follow-up data were collected retrospectively. RESULTS: Twenty-four patients were analysed; median follow-up was 18.5 months [6.75-34.25]. Exclusively medical treatment was effective in three of four patients, but, based on intention to treat, medical therapy alone was effective in only two out of 24 patients. Of 17 patients treated endoscopically, treatment was successful in 15 of them. Of the 15 who underwent surgery, external surgical drainage was effective in 13. Multimodal treatment, initiated after 6.5 days [4-13.5] of medical treatment, was effective in 12 out of 14 patients. In total, 21 patients were successfully treated (87%) with a morbidity rate of 79% and a mortality rate of 12.5% (n=3). CONCLUSION: PA gives rise to significant morbidity and mortality. Conservative medical treatment has only a limited role. If medical treatment fails, endoscopic and then surgical treatment allow a favourable outcome in more than 80% of patients.


Asunto(s)
Seudoquiste Pancreático , Pancreatitis Alcohólica , Ascitis/etiología , Ascitis/terapia , Drenaje/efectos adversos , Humanos , Seudoquiste Pancreático/etiología , Pancreatitis Alcohólica/complicaciones , Pancreatitis Alcohólica/terapia , Estudios Retrospectivos , Resultado del Tratamiento
11.
J Visc Surg ; 158(2): 125-132, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-32595025

RESUMEN

STUDY OBJECTIVE: It has been demonstrated that mortality following pancreatectomy is correlated with surgical volume. However, up until now, no French study has focused on predictive factors to undergo pancreatectomy in low-volume centers. The objective of this study is to analyze the clinical characteristics, socio-economic status and medical density according to surgical volume and to analyze predictive factors for undergoing pancreatectomy in low-volume centers. PATIENTS AND METHODS: All patients who underwent pancreatectomy in France from 2012 to 2015 were identified fromthe PMSI database. Hopsitals were classified as low, intermediate and high volume (<10, 11-19, ≥20 resections/year, respectively). Clinical and socioeconomic data, travel distance and rurality were assesed to identify factors associated with undergoing pancreatectomy at low-volume hospitals. RESULTS: In overall, 12,333 patients were included. Those who underwent pancreatectomy in low-volume centers were more likely older, had high Charlson comorbidity index (CCI), had low socioeconomic status, and resided in rural locations.distance traveled by patients operated on in low-volume centers was significantly shorter (23 vs. 61km, P<0.001). In multivariable analysis, older age (P=0.04), CCI≥4 (P=0.008), short travel distance (P<0.001), low socio-economic status (P<0.001) and rurality (P<0.001) were associated withundergoing pancreatectomy in low-volume centers. CONCLUSION: Patients continue to undergo pancreatectomy at low-volume hospitals is due not only to clinical parameters, but also to socioeconomic and environmental factors. These factors should be taken into account in process of pancreatic surgery centralization.


Asunto(s)
Hospitales de Alto Volumen , Hospitales de Bajo Volumen , Anciano , Bases de Datos Factuales , Humanos , Pancreatectomía , Viaje
12.
Infect Dis Now ; 51(5): 456-463, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33853752

RESUMEN

OBJECTIVES: Postoperative infections occur frequently after pancreaticoduodenectomy, especially in patients with bile colonization. Recommendations for perioperative anti-infectious treatment are lacking, and clinical practice is heterogenous. We have analyzed the effects of bile colonization and antibiotic prophylaxis on postoperative infection rates, types and therapeutic consequences. METHODS: Retrospective observational study in patients undergoing pancreaticoduodenectomy with intraoperative bile culture. Data on postoperative infections and non-infectious complications, bile cultures and antibiotic prophylaxis adequacy to biliary bacteria were collected. RESULTS: Among 129 patients, 53% had a positive bile culture and 23% had received appropriate antibiotic prophylaxis. Postoperative documented infection rate was over 40% in patients with or without bile colonization, but antibiotic therapy was more frequent in positive bile culture patients (77% vs. 57%, P=0,008). The median duration of antibiotic therapy was 11 days and included a broad-spectrum molecule in 42% of cases. Two-thirds of documented postoperative infections involved one or more bacteria isolated in bile cultures, which was associated with a higher complication rate. While bile culture yielded Gram-negative bacilli (57%) and Gram-positive cocci (43%), fungal microorganisms were scarce. Adequate preoperative antibiotic prophylaxis according to bile culture was not associated with reduced infectious or non-infectious complication rates. CONCLUSION: Patients undergoing pancreaticoduodenectomy experience a high rate of postoperative infections, often involving bacteria from perioperative bile culture when positive, with no preventive effect of an adequate preoperative antibiotic prophylaxis. Increased postoperative complications in patients with bile colonization may render necessary a perioperative antibiotic treatment targeting bile microorganisms. Further prospective studies are needed to improve the anti-infectious strategy in these patients.


Asunto(s)
Pancreaticoduodenectomía , Infección de la Herida Quirúrgica , Profilaxis Antibiótica , Humanos , Incidencia , Pancreaticoduodenectomía/efectos adversos , Complicaciones Posoperatorias/epidemiología , Infección de la Herida Quirúrgica/epidemiología
13.
RSC Adv ; 11(18): 10479-10488, 2021 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-35423574

RESUMEN

Solid oxide cells (SOCs) are electrochemical devices that convert the chemical energy of a fuel into electricity. With regard to electrodes, the development of materials with mixed conduction properties is a key issue for improving the performance of SOCs at high temperatures. New Cu and Nb co-doping La1-x Sr x Fe y Co1-y O3-δ (LSCF) materials were studied as electrode materials on yttria-stabilized zirconia (YSZ) supports. The results show that Cu0.05 + Nb0.05 co-doped LSCF maintains a stable cubic structure even after several heat treatments and has better conductivity than a classically used LSCF.

14.
Cell Mol Biol (Noisy-le-grand) ; 56 Suppl: OL1373-84, 2010 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-20937225

RESUMEN

The involvement of human papillomavirus in the development of cervical cancer has been firmly established. However, better management of cervical cancer rests on good diagnosis and an effective therapy. In this study we evaluated the frequency of point mutations in epidermal growth factor receptor (EGFR) for future use of tyrosine kinase inhibitors in clinical treatment and to assess the use of EGFR, p16INK4a and E-cadherin as biomarkers in cervical cancer diagnosis with immunohistochemistry. Fifty-three patient specimens of cervical cancer were analysed for HPV infection, for EGFR mutations in exons 18 through 21, and for expression of EGFR, p16INK4a and E-cadherin by immunostaining. Results showed that 79.24% of the cases (42/53) are HPV positive and the HPV types more closely associated with risk are HPV 16 and 18. In all 53 analysed specimens, any mutation affecting the EGFR kinase domain in exons 18 through 21 was observed. Expressions of EGFR, p16INK4a and E-cadherin were detected in 88,67% (47/53), 92,45% (49/53) and 79,24% (42/53) of analysed specimens respectively. Thus, EGFR, p16INK4a and E-cadherin would be excellent tools for IHC analysis during the cervical cancer development. EGFR and p16INK4a can be used for early diagnosis and E-cadherin for cancer progression and cell migration. However, treatment of cervical cancer with TKIs may not be effective and the identification of other EGFR inhibitors is needed.


Asunto(s)
Cadherinas/metabolismo , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Receptores ErbB/metabolismo , Neoplasias del Cuello Uterino/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Receptores ErbB/genética , Exones , Femenino , Papillomavirus Humano 16/genética , Papillomavirus Humano 18/genética , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Marruecos , Infecciones por Papillomavirus/complicaciones , Mutación Puntual , Análisis de Secuencia de ADN , Neoplasias del Cuello Uterino/complicaciones , Neoplasias del Cuello Uterino/diagnóstico
15.
Prog Urol ; 20(13): 1227-9, 2010 Dec.
Artículo en Francés | MEDLINE | ID: mdl-21130405

RESUMEN

Persistent Müllerian ducts syndrome is a rare form of internal male pseudohermaphroditism, characterized by the presence of the uterus, fallopian tubes and upper vagina in an otherwise normally virilised male with a 46 XY karyotype. It is the result of a deficiency in anti-Müllerian hormone or abnormality of this hormone receptor. Often, the diagnosis is made incidentally during surgical exploration for cryptorchidism or herniorrhaphy, and exceptionally during cancer of ectopic testis. We discuss a rare case of this syndrome revealed by a bilateral intra-abdominal gonadal tumor.


Asunto(s)
Criptorquidismo/complicaciones , Neoplasias Testiculares/complicaciones , Adulto , Trastorno del Desarrollo Sexual 46,XY/complicaciones , Humanos , Masculino
16.
Ann Cardiol Angeiol (Paris) ; 69(2): 81-85, 2020 Apr.
Artículo en Francés | MEDLINE | ID: mdl-32127198

RESUMEN

BACKGROUND: Although progression of coronary artery calcification (CAC) has been established as an important marker for cardiovascular morbidity, very few studies have studied it in end-stage renal disease patients. Thus we examined and evaluate risk factors of calcification changes in dialysis patients. METHOD: Among 28 hemodialysis (HD) patients, CAC was measured in Agatston units at baseline and after five years using the 64 multi-slice ultra-fast CT. The HD patients were classified as progressors or no progressors according to the change in the CAC score across these 2 measurements. RESULTS: Over an average 63 months follow-up, participants without CAC at baseline had no incident CAC. The progression of CAC was slow and was found only in 6 patients (21.4%). It was significantly associated with several cardiovascular risk factors, namely, older age (P=0.03), diabetes (P=0.05), male sex (P=0.02), hypercholesterolemia (P=0.05), anemia (P=0.017), inflammation (P=0.05), and hyperphosphataemia (P=0.012). However, calcemia, parathormone levels, dialysis duration, tobacco, high blood pressure and dialysis dose did not seem to influence the progression of CAC in our series. A strong association was found between basal calcification scores and Delta increment at 5 years. CONCLUSIONS: Our study suggests that CAC progression in dialysis is a complex phenomenon, associated with several risk factors with special regard to elevated basal scores. This progression can be avoided or slowed with appropriate management, which must begin in the early stages of chronic kidney disease.


Asunto(s)
Enfermedad de la Arteria Coronaria/patología , Progresión de la Enfermedad , Diálisis Renal/efectos adversos , Calcificación Vascular/patología , Adulto , Factores de Edad , Anciano , Anemia/complicaciones , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Angiopatías Diabéticas/complicaciones , Femenino , Humanos , Hipercolesterolemia/complicaciones , Hiperfosfatemia/complicaciones , Masculino , Persona de Mediana Edad , Diálisis Renal/estadística & datos numéricos , Factores de Riesgo , Factores Sexuales , Factores de Tiempo , Calcificación Vascular/diagnóstico por imagen
17.
J Visc Surg ; 157(5): 410-417, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32473822

RESUMEN

Neoplastic gallbladder polyps (NGP) are rare; the prevalence in the overall population is less than 10%. NGP are associated with a risk of malignant degeneration and must be distinguished from other benign gallbladder polypoid lesions that occur more frequently. NGP are adenomas and the main risk associated with their management is to fail to detect their progression to gallbladder cancer, which is associated with a particular poor prognosis. The conclusions of the recent European recommendations have a low level of evidence, based essentially on retrospective small-volume studies. Abdominal sonography is the first line study for diagnosis and follow-up for NGP. To prevent the onset of gallbladder cancer, or treat malignant degeneration in its early phases, all NGP larger than 10mm, or symptomatic, or larger than 6mm with associated risk factors for cancer (age over 50, sessile polyp, Indian ethnicity, or patient with primary sclerosing cholangitis) are indications for cholecystectomy. Apart from these situations, simple sonographic surveillance is recommended for at least five years; if the NGP increases in size by more than 2mm in size, cholecystectomy is indicated. Laparoscopic cholecystectomy is possible but if the surgeon feels that the risk of intra-operative gallbladder perforation is high, conversion to laparotomy should be preferred to avoid potential intra-abdominal tumoral dissemination. When malignant NGP is suspected (size greater than 15mm, signs of locoregional extension on imaging), a comprehensive imaging workup should be performed to search for liver extension: in this setting, radical surgery should be considered.


Asunto(s)
Adenoma/terapia , Neoplasias de la Vesícula Biliar/terapia , Pólipos/terapia , Adenoma/diagnóstico , Adenoma/patología , Colecistectomía/métodos , Diagnóstico Diferencial , Progresión de la Enfermedad , Neoplasias de la Vesícula Biliar/diagnóstico , Neoplasias de la Vesícula Biliar/patología , Humanos , Imagen por Resonancia Magnética , Pólipos/diagnóstico , Pólipos/patología , Pronóstico , Ultrasonografía , Espera Vigilante
18.
Ann Cardiol Angeiol (Paris) ; 68(3): 144-149, 2019 Jun.
Artículo en Francés | MEDLINE | ID: mdl-30683479

RESUMEN

Intra dialytic hypotension is the most common complication in hemodialysis. However, isolated diastolic hypotension (IDH) in hemodialysis is asymptomatic and its detection requires repeated monitoring of blood pressure during dialysis sessions. To study this phenomenon, we conducted a prospective study over a period of 5 years in 45 chronic hemodialysis patients. The IDH, was noted in 42% at inclusion, and in 59,5% of the cases at the end of the study. IDH was associated with advanced age, female gender, high relative critical blood volume, cardiac arrhythmias and diastolic dysfunction of the left ventricle. IDH was also significantly associated with novel cardiovascular complications (P=0.004) and all-cause mortality (P=0.038). Isolated diastolic hypotension is a particularly common phenomenon in hemodialysis. Our data encourage in-depth reflection on this subject in hemodialysis. In addition, our study highlights the value of screening for IDH by close monitoring of hemodynamic parameters, and calls for personalized dialysis management based on the analysis of the demonstrated risk factors and on the study of the associated comorbidities.


Asunto(s)
Enfermedades Asintomáticas , Hipotensión/diagnóstico , Diálisis Renal/efectos adversos , Adulto , Factores de Edad , Anciano , Arritmias Cardíacas/complicaciones , Volumen Sanguíneo , Causas de Muerte , Distribución de Chi-Cuadrado , Diástole , Femenino , Cardiopatías/etiología , Humanos , Hipotensión/complicaciones , Hipotensión/mortalidad , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Estudios Prospectivos , RecQ Helicasas , Factores de Riesgo , Estadísticas no Paramétricas , Sístole , Factores de Tiempo , Disfunción Ventricular Izquierda/complicaciones
19.
J Visc Surg ; 155(6): 465-470, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29706580

RESUMEN

OBJECTIVE: To define the cost of pancreatectomies and to identify factors associated with increased hospital costs after pancreatic resection. METHODS: All patients undergoing pancreatic surgery in our department between January 2008 and December 2014 were included. All complications occurring during hospitalization or in the 90-day period after discharge were documented. The hospital costs were analyzed and predictive factors of increased hospital costs were determined. RESULTS: One hundred and twenty seven patients were identified. Most patients underwent pancreatectomy for malignant tumors (70%). Median hospital costs were 21,392 [15,998-29,667] euros. Age (P=0.011) and preoperative jaundice (P<0.001) were associated with higher hospital costs. Intraoperative surgical time and blood loss were correlated with increased costs (P=0.001 and P=0.002, respectively). Pancreatoduodenectomy was associated with statistically significantly higher costs compared to distal pancreatectomy (21,770 vs. 15,422 euros, P=0.001). Severe postoperative complications (Clavien-Dindo grade≥3) (P=0.001), septic complications (P=0.002) and hemorrhage (P=0.001) statistically significantly increased costs. In multivariate analysis, septic (P=0.003) and severe complications (P=0.01) were statistically significantly associated with increased hospital costs. CONCLUSION: Pancreatic surgery is associated with high hospital costs, essentially related to postoperative complications.


Asunto(s)
Costos de Hospital , Páncreas/cirugía , Pancreatectomía/economía , Pancreaticoduodenectomía/economía , Complicaciones Posoperatorias/economía , Adenocarcinoma/cirugía , Factores de Edad , Pérdida de Sangre Quirúrgica , Femenino , Francia , Humanos , Ictericia/complicaciones , Ictericia/economía , Masculino , Persona de Mediana Edad , Tempo Operativo , Pancreatectomía/efectos adversos , Pancreatectomía/métodos , Neoplasias Pancreáticas/cirugía , Pancreaticoduodenectomía/efectos adversos , Pancreaticoduodenectomía/métodos , Hemorragia Posoperatoria/economía , Estudios Retrospectivos , Sepsis/economía
20.
Rev Neurol (Paris) ; 163(8-9): 829-32, 2007 Sep.
Artículo en Francés | MEDLINE | ID: mdl-17878810

RESUMEN

SUNCT syndrome is a rare form of a primary headache disorder, although secondary causes, particularly posterior fossa abnormalities, are well known. We report a new case in a 67-year-old man suffering SUNCT syndrome secondary to pyogenic cerebral abscess and empyema localized in the convexity portion of the right frontal lobe.


Asunto(s)
Absceso Encefálico/complicaciones , Empiema Subdural/complicaciones , Síndrome SUNCT/complicaciones , Anciano , Absceso Encefálico/patología , Empiema Subdural/patología , Lóbulo Frontal/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Síndrome SUNCT/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA